Barbara Horvath

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 155 publications

Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review.

Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review.

Journal: Acta dermato-venereologica

Published: May 07, 2026

Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling.

Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling.

Journal: Journal of translational autoimmunity

Published: April 08, 2026

Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.

Journal: Dermatology and therapy

Published: February 15, 2026

HiSCR is not PASI: Misleading primary outcomes in hidradenitis suppurativa clinical trials.

HiSCR is not PASI: Misleading primary outcomes in hidradenitis suppurativa clinical trials.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 12, 2026

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab.

Rituximab resistant pemphigus vulgaris successfully treated with obinutuzumab.

Journal: JAAD case reports

Published: December 25, 2025

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

Emerging Treatments in Pemphigus: Is Healing an Achievable Goal?

Journal: American journal of clinical dermatology

Published: December 04, 2025

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

VEXAS syndrome as an underlying cause of disease in patients with Sweet syndrome.

Journal: JAAD case reports

Published: December 03, 2025

International development of Investigator Global Assessment scores for pemphigus.

International development of Investigator Global Assessment scores for pemphigus.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: November 27, 2025

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.

Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach.

Journal: JAMA dermatology

Published: November 26, 2025

Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases: An Exploratory Survey among Dutch Patients.

Patient Perspectives on Treatment Outcomes and Priorities in Autoimmune Bullous Diseases: An Exploratory Survey among Dutch Patients.

Journal: Dermatology (Basel, Switzerland)

Published: November 17, 2025

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

Clinical Phenotype Transition in Pemphigus May Suggest Undertreatment with Rituximab: Findings from a Retrospective Single-Centre Analysis of Relapsed Patients.

Journal: Dermatology (Basel, Switzerland)

Published: August 26, 2025

Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.

Delphi consensus: First-line use of biologics and small molecules in hidradenitis suppurativa.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: August 24, 2025

Showing 1-12 of 155

Last Updated: 09/26/2026